Nona Biosciences
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway, Cambridge, Massachusetts, 02...Phone Number
(617) 410-8904Website
www.nonabio.comRevenue
$16.9 MillionIndustry
About Nona Biosciences
Nona Biosciences Org Chart
Is Nona Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Nona Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Nona Biosciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Nona Biosciences
Product Launch: Get notified when Nona Biosciences launches new products
Nona Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Nona Biosciences recently announced quarterly report
Check if Nona Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Nona Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Nona Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to Nona Biosciences
Compare insights from companies similar to Nona Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nona Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nona Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nona Biosciences.
Nona Biosciences Tech Stack
A closer look at the technologies used by Nona Biosciences
Most Recent Scoops
Nona Biosciences News & Media
Nona Biosciences and Valink Therapeutics Form Strategic Alliance to Accelerate Novel Biologics Discovery
CAMBRIDGE, Mass., Dec. 17, 2025 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company providing integrated solutions for biological drug discovery and development from "Idea to IND" (I to I®), and Valink Therapeutics ("Valink"), a private biotechnology company...Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery
Agreement includes license to Nona's fully human HCAb platform for preclinical antibody discovery CAMBRIDGE, Mass., Nov. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I®...Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies
CAMBRIDGE, Mass., Nov. 5, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), today announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the clinical-stage leader of in vivo cell...Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies
CAMBRIDGE, Mass., Nov. 5, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), today announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR-T cells. This agreement represents an expansion of the strategic collaboration established between the two companies in September 2024. The expanded part
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nona Biosciences
Nona Biosciences specializes in pioneering fully human heavy chain only antibodies and advanced single-domain antibody technology, aimed at accelerating the development of next-generation therapeutic modalities such as bispecifics, ADCs, and CAR-T therapies. Their proprietary Harbour Mice platform supports antibody discovery and development, while... Read More
